The latest medical insurance policy for Lenalidomide
Lenalidomide (Lenalidomide) is an important drug that belongs to the class of immunomodulators. It is widely used in the medical field and is mainly used to treat a variety of malignant hematological diseases and immune system-related diseases. The drug's main mechanisms of action include regulating the immune system, inhibiting tumor cell proliferation, reducing angiogenesis, etc., thus providing patients with an effective treatment option.
Lenalidomide has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price is around 3,500~4,000 yuan. Due to different medical insurance policies in various places, the price also varies. Please consult your local pharmacy for specific prices. There are also original research drugs in China, but the price is as high as tens of thousands of yuan, so it is not recommended to buy them. The cheaper ones abroad are mainly generic drugs, including those from India, Bangladesh, and Laos, which cost about a few hundred yuan per box. The ingredients of foreign generic drugs and domestic lenalidomide drugs are basically the same.

One of the most common indications for lenalidomide is multiple myeloma (Multiple Myeloma ). Multiple myeloma is a malignant blood disease caused by an abnormal proliferation of malignant plasma cells in the bone marrow and is often accompanied by symptoms such as anemia, bone pain, and impaired kidney function. Lenalidomide is used together with other drugs to help control the progression of the disease and improve patients' survival rate and quality of life.
In addition, lenalidomide is also used to treat high-risk myelodysplastic syndrome (MDS) and other diseases. MDSis a group of bone marrow disorders in which the bone marrow does not produce healthy blood cells properly, leading to anemia and other blood problems. Lenalidomide helps improve hematopoietic function and relieve anemia symptoms.
In summary, lenalidomide is an immunomodulatory drug that combats hematological malignancies and immune system-related diseases through multiple mechanisms. It plays an important role in improving patient survival, alleviating disease symptoms and improving quality of life, but it needs to be used under the supervision of a doctor as it may induce some side effects that require regular monitoring and management.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)